Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Follow-Up Questions
¿Cuál es el ratio P/E de Bruker Corp (BRKRP)?
El ratio P/E de Bruker Corp es 48.628
¿Quién es el CEO de Bruker Corp?
Dr. Frank Laukien es el Chairman of the Board de Bruker Corp, se unió a la empresa desde 1991.
¿Qué tal es el rendimiento del precio de la acción BRKRP?
El precio actual de BRKRP es de $300.23, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Bruker Corp?
Bruker Corp pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Bruker Corp?
La capitalización bursátil actual de Bruker Corp es $45.5B
¿Es Bruker Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 16 analistas han realizado calificaciones de análisis para Bruker Corp, incluyendo 6 fuerte compra, 6 compra, 8 mantener, 1 venta, y 6 fuerte venta
